Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 657Carcinoma, Renal Cell 384Carcinoma, Non-Small-Cell Lung 242Urinary Bladder Neoplasms 235Breast Neoplasms 221Melanoma 193Ovarian Neoplasms 191Neoplasms 178Colorectal Neoplasms 160Kidney Neoplasms 152Neoplasm Metastasis 131Carcinoma, Transitional Cell 126Pancreatic Neoplasms 124Lung Neoplasms 121Stomach Neoplasms 113Squamous Cell Carcinoma of Head and Neck 106Sarcoma 99Head and Neck Neoplasms 89Uterine Cervical Neoplasms 87Carcinoma, Hepatocellular 79Triple Negative Breast Neoplasms 75Esophageal Neoplasms 75Endometrial Neoplasms 74Colonic Neoplasms 64Wilms Tumor 56Small Cell Lung Carcinoma 54Carcinoma, Ovarian Epithelial 48Neuroblastoma 47Liver Neoplasms 46Testicular Neoplasms 45

Interventions

Metformin 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Castration Sensitive Prostate Cancer × Genitourinary × Clear all
NCT06044025 2026-01-15

A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

University of Arkansas

Phase 1 Recruiting
34 enrolled
Genitourinary

Castration Sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡